Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q22299211)
Watch
English
Standard therapy of advanced Hodgkin lymphoma
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Standard therapy of advanced Hodgkin lymphoma
(English)
0 references
main subject
Hodgkin lymphoma
1 reference
based on heuristic
inferred from title
author name string
J. Kuruvilla
series ordinal
1
author given names
John
author last names
Kuruvilla
1 reference
stated in
PubMed
PubMed ID
20008235
retrieved
30 March 2023
language of work or name
English
0 references
publication date
1 January 2009
0 references
published in
Hematology / the Education Program of the American Society of Hematology
1 reference
stated in
PubMed
volume
2009
0 references
issue
1
0 references
page(s)
497-506
0 references
cites work
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiation therapy salvage of Hodgkin's disease following chemotherapy failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical radiotherapy as salvage treatment for relapse of Hodgkin's disease initially treated by chemotherapy alone: prognostic significance of the disease-free interval.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effectiveness of radiotherapy for localized relapse in patients with Hodgkin's disease (IIB-IVB) who obtained a complete response with chemotherapy alone as initial treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle L
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of Hodgkin's disease trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salvage radiotherapy in recurrent Hodgkin's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autologous transplantation in relapsed and refractory Hodgkin's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FASHEDUCATION-2009.1.497
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1182/ASHEDUCATION-2009.1.497
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4895931
OpenCitations bibliographic resource ID
4895931
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4895931
PubMed ID
20008235
0 references
ResearchGate publication ID
40685975
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
